EarliPoint Health
PrivateLast Round
Series B
Apr 2, 2024
Total Funding Raised
$41M
Company Overview
EarliPoint Health is a healthcare technology company that develops and commercializes an FDA-cleared device to aid in the early diagnosis and assessment of Autism Spectrum Disorder (ASD) in children.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EarliPoint Health Comps
Public and private peers based on sector, stage, and business model.
EarliPoint Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 2, 2024 | ||||
| Series A | Feb 18, 2022 |
EarliPoint Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Clarevia Ventures | Series B |
| Nexus NeuroTech Ventures | Series B |
| GRA Venture Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 2, 2024
$22M round led by Clarevia Ventures and Nexus NeuroTech Ventures.
- Feb 18, 2022
$20M round led by Bernard Marcus
EarliPoint Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EarliPoint Health's valuation, stock price, and market status.
